Stokes WA, et al. – This study focused on the patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States. Collected data represented that the increased utilization of hypofractionation (HypoFxn) for T2N0M0 glottic cancer was driving national practice patterns away from conventional fractionation (CFxn). The authors of this study supported the use of altered fractionation, particularly HypoFxn, for patients undergoing definitive radiotherapy.